Wooridul Huebrain Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 16, 2022 at 03:12 am EDT
Share
Wooridul Huebrain Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 863.57 million compared to KRW 38.34 million a year ago. Net loss was KRW 16,294.76 million compared to net income of KRW 10,435.66 million a year ago. Basic loss per share from continuing operations was KRW 193 compared to basic earnings per share from continuing operations of KRW 250 a year ago. Diluted loss per share from continuing operations was KRW 193 compared to diluted earnings per share from continuing operations of KRW 192 a year ago. Basic loss per share was KRW 193 compared to basic earnings per share of KRW 195 a year ago.
For the six months, sales was KRW 1,545.83 million compared to KRW 55.28 million a year ago. Net loss was KRW 19,335.66 million compared to net income of KRW 9,625.68 million a year ago. Basic loss per share from continuing operations was KRW 233 compared to basic earnings per share from continuing operations of KRW 226 a year ago. Diluted loss per share from continuing operations was KRW 233 compared to diluted earnings per share from continuing operations of KRW 196 a year ago. Basic loss per share was KRW 233 compared to basic earnings per share of KRW 186 a year ago.
SMeDi Co Ltd, formerly The MediPharm Co Ltd, is a Korea-based company primarily engaged in the pharmaceutical distribution business. The Company operates through five segments. The Pharmaceuticals Business segment is engaged in the distribution of pharmaceuticals including recapsules and tablets. The Medical Business segment is engaged in the distribution of medical devices and medical supplies. The Wireless Device segment is engaged in the manufacture of wearable wireless devices. The Video Content segment is engaged in the production of video products. The Investment segment is engaged in the management consulting and investment businesses.